About US
Contact us
-
Pharma dealmaking boosts M&A to record-setting heights in Q1No surprise that the health industry is setting records,M&A-wise. According to PricewaterhouseCoopers, life sciences companies inked 35 deals worth $166.3 billion in Q1--more than all of 2014's tr2015/5/8
-
Tiny drugmakers top list of most profitable, but Shire and Gilead are there, tooWho are the most profitable companies in healthcare? Drug companies, with 7 out of 10 slots on a ranking by profit margin. Who are the most profitable drug companies? You might scratch your heads at a2015/5/8
-
IBM's new healthcare biz gets to work on personalized cancer treatmentsIBM ($IBM) is unleashing Watson on healthcare. After scoring a trifecta of big-name deals--with Apple ($AAPL), Medtronic ($MDT) and Johnson & Johnson ($JNJ)--the tech heavyweight's brand-new healt2015/5/7
-
Pharma hikes prices on all sorts of meds, but hit diabetes hardest: BloombergHere are more stats for the price-increase tally: Twenty-seven drug brands took 20% price increases last year, and dozens saw prices at least double over the past 5 years,Bloombergreports. Once again,2015/5/7
-
Hampton steps into GSK chairman role as discontent with Witty buildsGlaxoSmithKline's ($GSK) new chairman has his work cut out for him. The British drugmaker has sluggish sales in the U.S. and revenue growth that falls behind that of its Big Pharma rivals. It also rec2015/5/6
-
Zoetis, under pressure from activist investor Ackman, will offload 10 plants to cut costsAnimal health leader Zoetis ($ZTS) is using a move out of the Amgen ($AMGN) playbook, whacking on manufacturing to cut costs and appease an aggressive activist investor. Zoetis announced in its first-2015/5/6
-
Prepping for spendy launches, pharma execs take a hint from Gilead's pricing fightAs payers continue to flex their drug-pricing muscles, it's more important for drugmakers to land on their good sides--especially as companies prepare to roll pricey treatments onto the market. And ph2015/5/5
-
WuXi starts up construction of China's largest biologics plantWuXi Biologics is embarking on construction of a new manufacturing facility that will be the biggest biologics plant inChina. It'll also be the world's largest facility for mammalian cell culture manu2015/5/5
-
Small group of branded drugs like Nexium, Copaxone make up huge part of Medicare spendIt's a good thing for Medicare that AstraZeneca's ($AZN)Nexiumhas gone generic and Teva's ($TEVA)Copaxoneis headed that way. That is because they are among about 10% of the drugs covered by Medicare w2015/5/4
-
GSK weighing scrapping investor payout to boost dividend insteadAnalysts are suggesting that GlaxoSmithKline ($GSK) is thinking hard about scrapping a plan to reward investors by paying them about £4 billion and instead use money from its deals with Novartis2015/5/4